Morrison P J, Johnston W P, Nevin N C
Department of Medical Genetics, Queen's University of Belfast, Belfast City Hospital, UK.
J Med Genet. 1995 Jul;32(7):524-30. doi: 10.1136/jmg.32.7.524.
A survey of Huntington's disease (HD) in Northern Ireland, with a population of 1.5 million, has shown a 1991 prevalence rate of 6.4/100,000. Virtually complete ascertainment was achieved, enabling prevalence rate estimates and age statistics to be calculated over the last 20 years. The prevalence rate is similar to the high prevalence rates of HD found in most European populations, suggesting the presence of either one extremely ancient or a number of separate mutational origins, resulting in a uniform European HD prevalence. The ages at diagnosis and duration of the disease are similar to previous studies, suggesting a consistent effect of the HD gene in all families. Estimates of heterozygote frequency (HF), direct and indirect mutation rate, fertility, and genetic fitness (W) were made. Reliable HF estimates gave values between 10 and 11 x 10(-5). The direct and indirect mutation rates were 0.32 x 10(-6) and 1.05 x 10(-6) respectively. W was increased in the affected HD population but decreased in the at risk population. Fertility in HD is not reduced, but it appears that at risk patients have actively limited their family size. Factors responsible include, among others, the fear of developing HD and genetic counselling of families. This is the first published epidemiological survey to include ascertainment data in a population both before and after isolation of the HD gene, and with the diagnosis in virtually all patients confirmed by DNA mutation testing.
在北爱尔兰进行的一项针对亨廷顿舞蹈症(HD)的调查显示,在150万人口中,1991年的患病率为6.4/10万。几乎实现了完全确诊,从而能够计算过去20年的患病率估计值和年龄统计数据。该患病率与大多数欧洲人群中发现的HD高患病率相似,这表明存在一个极其古老的突变起源或多个独立的突变起源,导致欧洲HD患病率一致。诊断年龄和疾病持续时间与先前的研究相似,表明HD基因在所有家族中具有一致的作用。对杂合子频率(HF)、直接和间接突变率、生育率以及遗传适合度(W)进行了估计。可靠的HF估计值在10至11×10⁻⁵之间。直接和间接突变率分别为0.32×10⁻⁶和1.05×10⁻⁶。在受影响的HD人群中W增加,但在高危人群中W降低。HD患者的生育率并未降低,但似乎高危患者主动限制了家庭规模。相关因素包括对患HD的恐惧以及对家庭的遗传咨询等。这是首次发表的流行病学调查,涵盖了HD基因分离前后人群的确证数据,且几乎所有患者的诊断均通过DNA突变检测得到证实。